PT1494703E - Quimiocinas mutantes que apresentam uma disponibilidade biologica oral melhorada - Google Patents
Quimiocinas mutantes que apresentam uma disponibilidade biologica oral melhoradaInfo
- Publication number
- PT1494703E PT1494703E PT03730169T PT03730169T PT1494703E PT 1494703 E PT1494703 E PT 1494703E PT 03730169 T PT03730169 T PT 03730169T PT 03730169 T PT03730169 T PT 03730169T PT 1494703 E PT1494703 E PT 1494703E
- Authority
- PT
- Portugal
- Prior art keywords
- chemiocines
- mutant
- improved oral
- biological availability
- oral biological
- Prior art date
Links
- 102000001902 CC Chemokines Human genes 0.000 abstract 1
- 108010040471 CC Chemokines Proteins 0.000 abstract 1
- 102000001326 Chemokine CCL4 Human genes 0.000 abstract 1
- 108010055165 Chemokine CCL4 Proteins 0.000 abstract 1
- 102000001327 Chemokine CCL5 Human genes 0.000 abstract 1
- 108010055166 Chemokine CCL5 Proteins 0.000 abstract 1
- 125000002091 cationic group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/195—Chemokines, e.g. RANTES
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02100339 | 2002-04-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1494703E true PT1494703E (pt) | 2006-05-31 |
Family
ID=28685984
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT03730169T PT1494703E (pt) | 2002-04-04 | 2003-03-31 | Quimiocinas mutantes que apresentam uma disponibilidade biologica oral melhorada |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7335350B2 (pt) |
| EP (1) | EP1494703B1 (pt) |
| JP (1) | JP2005529099A (pt) |
| AT (1) | ATE319471T1 (pt) |
| AU (1) | AU2003240758B2 (pt) |
| CA (1) | CA2480692A1 (pt) |
| DE (1) | DE60303929T2 (pt) |
| DK (1) | DK1494703T3 (pt) |
| ES (1) | ES2254938T3 (pt) |
| IL (1) | IL164375A0 (pt) |
| PT (1) | PT1494703E (pt) |
| SI (1) | SI1494703T1 (pt) |
| WO (1) | WO2003084562A1 (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2007815A2 (en) * | 2006-03-31 | 2008-12-31 | Biotherapix Molecular Medicines S.L.U. | Mono- and bifunctional molecules with ability to bind to g protein-coupled receptors |
| DK2185719T3 (en) | 2007-08-02 | 2014-02-17 | Novimmune Sa | ANTI-RANTES ANTIBODIES AND PROCEDURES FOR USE THEREOF |
| WO2011031757A1 (en) * | 2009-09-11 | 2011-03-17 | Centocor Ortho Biotech Inc. | Serum markers for identification of cutaneous systemic sclerosis subjects |
| WO2019229615A1 (en) | 2018-05-28 | 2019-12-05 | Université De Genève | Methods of inhibiting cerebral inflammation |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5739103A (en) * | 1993-11-12 | 1998-04-14 | Dana-Farber Cancer Institute | Chemokine N-terminal deletion mutations |
| US5871723A (en) * | 1995-06-06 | 1999-02-16 | The Regent Of The University Of Michigan | CXC chemokines as regulators of angiogenesis |
| WO1998006751A1 (en) | 1996-08-16 | 1998-02-19 | Research Corporation Technologies, Inc. | Mcp-3, rantes and mip-1alpha receptor antagonists |
| EP0972043A1 (en) | 1996-09-25 | 2000-01-19 | British Biotech Pharmaceuticals Limited | Human rantes mutants incapable of aggregate formation |
| US6214540B1 (en) * | 1997-03-26 | 2001-04-10 | University Of Maryland Biotechnology Institute | Chemokines that inhibit immunodeficiency virus infection and methods based thereon |
| CA2316447C (en) * | 1997-12-23 | 2009-07-28 | Fondazione Centro San Raffaele Del Monte Tabor | Rantes mutants and therapeutic applications thereof |
| JP3349439B2 (ja) | 1998-07-08 | 2002-11-25 | 日清紡績株式会社 | ポリアセタール樹脂組成物 |
| US6316420B1 (en) * | 1998-07-28 | 2001-11-13 | Technion Research And Development Foundation Ltd. | DNA cytokine vaccines and use of same for protective immunity against multiple sclerosis |
| AU2740900A (en) | 1999-01-29 | 2000-08-18 | Millennium Pharmaceuticals, Inc. | Method of treating demyelinating inflammatory disease using ccr1 antagonists |
| UA77950C2 (en) * | 2000-10-04 | 2007-02-15 | Applied Research Systems | Use of mutants of cc chemokines for treatment of multiple sclerosis |
-
2003
- 2003-03-31 SI SI200330205T patent/SI1494703T1/sl unknown
- 2003-03-31 DE DE60303929T patent/DE60303929T2/de not_active Expired - Lifetime
- 2003-03-31 AU AU2003240758A patent/AU2003240758B2/en not_active Ceased
- 2003-03-31 CA CA002480692A patent/CA2480692A1/en not_active Abandoned
- 2003-03-31 ES ES03730169T patent/ES2254938T3/es not_active Expired - Lifetime
- 2003-03-31 JP JP2003581802A patent/JP2005529099A/ja active Pending
- 2003-03-31 AT AT03730169T patent/ATE319471T1/de active
- 2003-03-31 WO PCT/EP2003/050084 patent/WO2003084562A1/en active IP Right Grant
- 2003-03-31 PT PT03730169T patent/PT1494703E/pt unknown
- 2003-03-31 DK DK03730169T patent/DK1494703T3/da active
- 2003-03-31 EP EP03730169A patent/EP1494703B1/en not_active Expired - Lifetime
- 2003-03-31 US US10/510,014 patent/US7335350B2/en not_active Expired - Fee Related
-
2004
- 2004-10-03 IL IL16437504A patent/IL164375A0/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003084562A1 (en) | 2003-10-16 |
| ES2254938T3 (es) | 2006-06-16 |
| US7335350B2 (en) | 2008-02-26 |
| US20050220759A1 (en) | 2005-10-06 |
| EP1494703B1 (en) | 2006-03-08 |
| AU2003240758A1 (en) | 2003-10-20 |
| JP2005529099A (ja) | 2005-09-29 |
| DK1494703T3 (da) | 2006-06-26 |
| DE60303929D1 (de) | 2006-05-04 |
| AU2003240758B2 (en) | 2008-03-13 |
| ATE319471T1 (de) | 2006-03-15 |
| SI1494703T1 (sl) | 2006-06-30 |
| IL164375A0 (en) | 2005-12-18 |
| CA2480692A1 (en) | 2003-10-16 |
| EP1494703A1 (en) | 2005-01-12 |
| DE60303929T2 (de) | 2006-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0307833A (pt) | Sìntese controlada de ziprasidona e suas composições | |
| BR9900320A (pt) | Composição antimicrobiana | |
| BR0312276A (pt) | Mimeticorpos ch1-removidos miméticos de epo de mamìfero, composições, métodos e usos | |
| HK1084404A1 (en) | Muteins of tear lipocalin | |
| BR0310092A (pt) | Combinação de compostos orgânicos | |
| HK1091112A1 (en) | Compounds and methods for increasing neurogenesis | |
| LU92433I2 (fr) | Olodatérol, ses isomères optiques individuels, mélanges d'énantiomères individuels ou de racémates, ses sels d'addition d'acide avec des acides pharmaceutiquement acceptables, ainsi que ses solvates et/ou ses hydrates, en particulier l'olodatérol et le chlorhydrate d'olodatérol | |
| BR0208142A (pt) | Combinações compreendendo um agente antidiarréico e epotilona ou derivado de epotilona | |
| ATE445376T1 (de) | Schraube zur befestigung der wirbelsäule | |
| WO2003106629A3 (en) | TREATMENT OF VITAMIN D INFLUENCED DISEASES | |
| BRPI0407950A (pt) | processo para a preparação de uma composição de higiene pessoal | |
| DE60143796D1 (de) | Füllungen und dentalmaterialkomposite diese füllungen enthaltend. | |
| EA200300929A1 (ru) | Новые лекарственные композиции на основе антихолинергических средств и ингибиторов pde-iv | |
| NO20035025L (no) | Anvendelse av osteopontin for behandling og/eller for a hindre nevrologiske sykdommer, samt farmasoytisk sammensetning omfattende osteopontin eller en antagonist med osteopontinaktivitet. | |
| IL163896A0 (en) | Piperidine or 8-aza-bicycloÄ3.2.1Üoct-3-yl derivatives useful as modulators of chemokine receptoractivity (especially ccr5) | |
| AR012193A1 (es) | Nuevas combinaciones terapeuticas | |
| PL1553162T3 (pl) | Toaletowe kostki | |
| BRPI0411324A (pt) | composições farmacêuticas e métodos de tratamento de resposta mediada por histamina em pacientes | |
| PT1494703E (pt) | Quimiocinas mutantes que apresentam uma disponibilidade biologica oral melhorada | |
| MA27862A1 (fr) | Composition pharmaceutique | |
| BR9811821A (pt) | 2-acilaminopropanaminas como antagonistas de receptores de taquicinina | |
| RS51534B (en) | NEW COMPOUND OF SINUSOID IF CURRENT INHIBITORS AND CALCIUM INHIBITOR AND PHARMACEUTICAL MIXTURE CONTAINED BY IT | |
| ES2175356T3 (es) | Uso de (+)-alfa-(2,3-dimetoxifenil)-1-[2-(4 fluorofenil)et il[-4- piperidinmetanol en el tratamiento de trastornos depresivos y trastornos bipolares. | |
| MY134019A (en) | Aryl oxime-piperazines useful as ccr5 antagonists | |
| IL175358A0 (en) | 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease |